Log In
BCIQ
Print this Print this
 

relugolix (TAK-385)

  Manage Alerts
Collapse Summary General Information
Company Takeda Pharmaceutical Co. Ltd.
DescriptionGonadotropin-releasing hormone (GnRH) receptor antagonist
Molecular Target GnRH/LHRH receptor
Mechanism of ActionGnRH/LHRH receptor antagonist
Therapeutic ModalityPeptide

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/07/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today